Form 4 for PASG Passage BIO, Inc.
Accepted 2022-11-18 00:00:00 ET · period of report 2022-09-15 · accession 0001209191-22-057891 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-18 | 2022-09-15 | PASG | Toernsen Monika Maria | Chief Commercial Off | M - OptEx | — | +5,000 | 5,000 | New | — |
| D | 2022-11-18 | 2022-09-19 | PASG | Toernsen Monika Maria | Chief Commercial Off | S - Sale+OE | $1.51 | -1,681 | 3,319 | -34% | -$2,538 |
| D | 2022-11-18 | 2022-09-15 | PASG | Toernsen Monika Maria | Chief Commercial Off | M - OptEx | $0.00 | -5,000 | 15.0K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-15 | M | A | 5,000 | — | 5,000 | D | — | — | (F1) Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2022-09-19 | S | D | 1,681 | $1.51 | 3,319 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2022-09-15 | M | D | 5,000 | $0.00 | 15,000 | D | — · — to 2031-07-18 | 5,000 Common Stock | (F3) Each RSU represents a contingent right to receive one share of Issuer's common stock. (F4) 1/4 of the RSUs vested on September 15, 2022, and the remainder will vest as to 1/4 of the total award in annual installments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date. |